← board
PLRZ
distress 6/10 · elevated risk$14.27-1%today-17% from 52w high
Revenue
pre-revenue
Liquidity
$1M
Runway
0.3 yrs
Shares 1y
0%
Price & events
-9.0% over 6M
CatalystRating changeDilutionFinancingdashed = today
-0.9%
1D
+9.7%
1W
+20.9%
1M
-3.5%
3M
-10.5%
6M
+26.5%
1Y
—
2Y
—
5Y
-99.4%
All
Overview
- Market Cap
- $22.94M
- Volume
- 6.87K
- 52 Week Range
- $3.13 – $17.17
- Total Shares
- 1.61M
- Float Shares
- 1.42M
- Short %
- 1.97%
- % Held by Insiders
- 0.83%
- % Held by Institutions
- 7.13%
- RVOL
- 0.17x
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.